Advertisement

Experimental Procedures for Demonstration of MicroRNA Mediated Enhancement of Functional Neuroprotective Effects of Estrogen Receptor Agonists

  • Mrinmay Chakrabarti
  • Swapan K. Ray
Part of the Methods in Molecular Biology book series (MIMB, volume 1366)

Abstract

Protection of motoneurons is an important therapeutic goal in the treatment of neurological disorders. Recent reports have suggested that specific microRNAs (miRs) could modulate the expression of particular proteins for significant alterations in the pathogenesis of different neurological disorders. Thus, combination of overexpression of a specific neuroprotective miR and treatment with a neuroprotective agent could be a novel strategy for functional protection of motoneurons. The protocols described herein demonstrate that miR-7-1, a neuroprotective miR, can enhance the functional neuroprotective effects of estrogen receptor agonists such as 1,3,5-tris(4-hydroxyphenyl)-4-propyl-1H-pyrazole (PPT), Way 200070 (WAY), and estrogen (E2) in preventing apoptosis in A23187 calcium ionophore (CI) exposed VSC4.1 motoneurons. This article describes the protocols for the cell viability assay, transfection of VSC4.1 motoneurons with miRs, Annexin V/propidium iodide staining for apoptosis, Western blotting, patch-clamp recording of whole-cell membrane potential, and JC-1 staining for detection of mitochondrial membrane potential. Taken together, these protocols are used to demonstrate that miR-7-1 caused significant enhancement of the efficacy of estrogen receptor agonists for functional neuroprotection in VSC4.1 motoneurons.

Key words

Apoptosis miR-7-1 PPT WAY Estrogen VSC4.1 motoneurons 

Notes

Acknowledgements

This work was supported in part by the grant SCIRF-11-002 from the South Carolina Spinal Cord Injury Research Foundation (Columbia, SC, USA) and also a grant from the United Soybean Board (USB, Chesterfield, MO, USA).

References

  1. 1.
    Hook MA, Moreno G, Woller S et al (2009) Intrathecal morphine attenuates recovery of function after a spinal cord injury. J Neurotraum 26:741–752CrossRefGoogle Scholar
  2. 2.
    Chakrabarti M, Banik NL, Ray SK (2014) miR-7-1 potentiated estrogen receptor agonists for functional neuroprotection in VSC4.1 motoneurons. Neuroscience 256:322–333CrossRefGoogle Scholar
  3. 3.
    Martina M, Kilić G, Cherubini E (1994) The effect of intracellular Ca2+ on GABA-activated currents in cerebellar granule cells in culture. J Membr Biol 142:209–216CrossRefGoogle Scholar
  4. 4.
    Wang X, Sada K, Yanagi S et al (1994) Intracellular calcium dependent activation of p72syk in platelets. J Biochem 116:858–861CrossRefGoogle Scholar
  5. 5.
    Rodriguez-Tarduchy G, Collins M, López-Rivas A (1990) Regulation of apoptosis in interleukin-3-dependent hemopoietic cells by interleukin-3 and calcium ionophores. EMBO J 9:2997–3002CrossRefGoogle Scholar
  6. 6.
    Caron-Leslie LA, Evans RB, Cidlowski JA (1994) Bcl-2 inhibits glucocorticoid-induced apoptosis but only partially blocks calcium ionophore or cycloheximide-regulated apoptosis in S49 cells. FASEB J 8:639–645CrossRefGoogle Scholar
  7. 7.
    Yan H, Hong P, Jiang M et al (2012) microRNAs as potential therapeutics for treating spinal cord injury. Neural Regen Res 7:1352–1359PubMedPubMedCentralGoogle Scholar
  8. 8.
    Liu NK, Xu XM (2011) microRNA in central nervous system trauma and degenerative disorders. Physiol Genomics 43:571–580CrossRefGoogle Scholar
  9. 9.
    Kusuda R, Cadetti F, Ravanelli MI et al (2011) Differential expression of microRNAs in mouse pain models. Mol Pain 7:7–17CrossRefGoogle Scholar
  10. 10.
    Li LC, Okino ST, Zhao H et al (2006) Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A 103:17337–17342CrossRefGoogle Scholar
  11. 11.
    Breving K, Esquela-Kerscher A (2010) The complexities of miR regulation: mirandering around the rules. Int J Biochem Cell Biol 42:1316–1329CrossRefGoogle Scholar
  12. 12.
    Smith RG, Alexianu ME, Crawford G et al (1994) Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line. Proc Natl Acad Sci U S A 91:3393–3397CrossRefGoogle Scholar
  13. 13.
    Chakrabarti M, Haque A, Banik NL et al (2014) Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration. Brain Res Bull 109:22–31CrossRefGoogle Scholar
  14. 14.
    Sribnick EA, Ray SK, Nowak MW et al (2004) 17beta-estradiol attenuates glutamate-induced apoptosis and preserves electrophysiologic function in primary cortical neurons. J Neurosci Res 76:688–696CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Department of Pathology, Microbiology, and ImmunologyUniversity of South Carolina School of MedicineColumbiaUSA
  2. 2.Department of Pathology, Microbiology, and ImmunologyUniversity of South Carolina School of MedicineColumbiaUSA

Personalised recommendations